Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-04

Clinical Trial Update: CGM - Reimagine Primary Care [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for CGM in primary care focusing on Type 2 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED